Rubius Therapeutics Inc (NASDAQ:RUBY)
| 0.2804 Delayed Data As of 3:59pm ET |  -0.0135 / -4.59%Today’s Change | 0.14 Today|||52-Week Range 6.54 | +60.23% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Epstein David R Director |  Buy | 4/21/2022 | 30,000 | $1.44 | $43.2K | -78.42% |
Appelhans Dannielle Chief Operating Officer |  Sale | 8/10/2022 | 5,737 | $0.80 | $4.6K | -64.73% |
Cagnoni Pablo J Director | Sale | 2/01/2023 | 8,448 | $0.25 | $2.1K | +3.11% |
Cagnoni Pablo J Director | Sale | 1/31/2023 | 7,240 | $0.24 | $1.7K | +6.87% |
Appelhans Dannielle President & Chief Executive Officer | Sale | 2/01/2023 | 3,878 | $0.25 | $969.50 | +3.11% |
Turka Laurence Chief Scientific Officer | Sale | 1/31/2023 | 2,593 | $0.24 | $622.32 | +6.87% |
Turka Laurence Chief Scientific Officer | Buy | 1/29/2023 | 7,438 | $0.00 | $0.00 | +9.61% |
Turka Laurence Chief Scientific Officer | Buy | 1/31/2023 | 8,625 | $0.00 | $0.00 | +6.87% |
Cagnoni Pablo J Director | Buy | 1/29/2023 | 21,250 | $0.00 | $0.00 | +9.61% |
Cagnoni Pablo J Director | Buy | 1/31/2023 | 25,000 | $0.00 | $0.00 | +6.87% |
Page of 2